ctrl K

Watchlist Price Alert

Bellerophon Therapeutics ... (BLPH)

NASDAQ: BLPH · Real-Time Price · USD

0.01

-0.01 (-47.37%)

At close: Dec 18, 2024, 5:51 PM

Bellerophon Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	65K	102K	147K	348K	362K	373K	400K
Gross Profit	-65K	-102K	-147K	-348K	-362K	-373K	-400K
Operating Income	-22.38M	-20.16M	-26.28M	-17.47M	-27.88M	-24.6M	-23.76M
Interest Income	n/a	n/a	n/a	n/a	378K	184K	95K
Pretax Income	-22.25M	-19.56M	-26.85M	-15.07M	-2.63M	-54.82M	-24.25M
Net Income	-19.83M	-17.76M	-24.73M	-13.27M	2.81M	-54.82M	-23.81M
Selling & General & Admin	6.02M	7.15M	8.39M	6.44M	7.62M	6.75M	7.11M
Research & Development	16.36M	13.02M	17.89M	11.03M	20.26M	17.85M	16.65M
Other Expenses	n/a	n/a	n/a	-674K	27.88M	24.6M	23.76M
Operating Expenses	22.38M	20.16M	26.28M	17.47M	27.88M	24.6M	23.76M
Interest Expense	135K	5K	250K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	22.38M	20.16M	26.28M	17.47M	27.88M	24.6M	23.76M
Income Tax Expense	-2.42M	-1.8M	-2.13M	-1.8M	-5.44M	29.85M	-438K
Shares Outstanding (Basic)	9.55M	9.5M	7.8M	4.5M	4.34M	2.6M	1M
Shares Outstanding (Diluted)	9.55M	9.5M	7.8M	4.5M	4.34M	2.6M	1M
EPS (Basic)	-2.08	-1.87	-3.17	-2.95	0.65	-21.11	-23.72
EPS (Diluted)	-2.08	-1.87	-3.17	-2.95	0.65	-21.11	-23.72
EBITDA	-22.18M	-20.16M	-26.71M	-14.72M	-2.26M	-54.45M	-23.85M
EBIT	-22.25M	-19.56M	-26.85M	-15.07M	-2.63M	-54.82M	-24.25M
Depreciation & Amortization	65K	102K	147K	348K	362K	373K	400K